Innovation Theater 8 (Mini) | Provided By: Vertex Pharmaceuticals Incorporated

---

Program Description

This program will review CF prevalence and unique aspects of the diagnosis of CF across racial and ethnic groups, how CF can present atypically as other idiopathic respiratory conditions including bronchiectasis, when to reconsider a prior diagnosis, and the criteria used to establish the diagnosis of CF. In addition, we will review the impact of a delayed diagnosis on long-term patient outcomes. For the discussion section, Dr. Solomon will review a case study of CF diagnosis in a patient previously misdiagnosed to highlight diagnostic challenges.

This program was developed by Vertex Pharmaceuticals Incorporated and is neither sponsored by nor endorsed by ATS and does not offer CME/CE credit. Vertex and the Vertex triangle logo are registered trademarks of Vertex Pharmaceuticals Incorporated.

©2026 Vertex Pharmaceuticals Incorporated

Speaker

Presenter: George M Solomon, M.D.
Marnix E. Heersink School of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
M.D.
Birmingham Alabama